Ovarian carcinosarcoma
Therapeutic area
Oncology
Rare disease
Yes
- Definition
- A highly aggressive malignant neoplasm arising from the ovary. Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Ovarian carcinosarcoma
- Therapeutic area
- Oncology
- ovarian carcinosarcoma
- Advanced Ovarian Carcinosarcoma
- carcinosarcoma of ovary
- carcinosarcoma of the ovary
- malignant mixed mesodermal Mullerian neoplasm of ovary
- malignant mixed mesodermal Müllerian neoplasm of ovary
- malignant mixed mesodermal Mullerian neoplasm of the ovary
- malignant mixed mesodermal Müllerian neoplasm of the ovary
- malignant mixed mesodermal Mullerian tumor of ovary
- malignant mixed mesodermal Müllerian tumor of ovary
- malignant mixed mesodermal Mullerian tumor of the ovary
- malignant mixed mesodermal Müllerian tumor of the ovary
- malignant mixed mesodermal Mullerian tumour of ovary
- malignant mixed mesodermal Müllerian tumour of ovary
- malignant mixed mesodermal Mullerian tumour of the ovary
- malignant mixed mesodermal Müllerian tumour of the ovary
- MMMT of the ovary
- ovarian malignant mesodermal (Mullerian) mixed tumor
- ovarian malignant mesodermal (Müllerian) mixed tumor
- ovarian malignant mesodermal (Mullerian) mixed tumour
- ovarian malignant mesodermal (Müllerian) mixed tumour
- ovarian malignant mixed epithelial mesenchymal tumor
- ovarian malignant mixed epithelial mesenchymal tumour
- ovarian malignant mixed mesodermal (Mullerian) tumor
- ovarian malignant mixed mesodermal (Müllerian) tumor
And 20 more, listed on the interactive page.
- Severity
- Severe
- Endocrinology
- Oncology
- Reproductive Health
Sources for recorded values
- MONDO ID
- MONDO:0003792
- Parent condition
- MONDO:0002928
Related records
Broader conditions (29)
- Cancer
- Cancer or benign tumor
- Carcinoma
- Carcinosarcoma
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Endocrine system disorder
- Endometrioid tumor
- Epithelial neoplasm
- Female reproductive organ cancer
- Female reproductive system disorder
- Female reproductive system neoplasm
- Gonadal disorder
- Human disease
- Malignant epithelial tumor of ovary
- Malignant mixed neoplasm
- Mixed neoplasm
- Neoplasm
- Neoplastic disease or syndrome
Trials (6)
- A Study of PHST001 in Advanced Solid Tumors
- Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
- Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)
Drugs in development (9)
- Carboplatin Phase 3
- Doxorubicin Phase 2
- Galunisertib Phase 1
- Ifosfamide Phase 3
- Ipilimumab Phase 2
- Lenvatinib Phase 2
- Nivolumab Phase 2
- Paclitaxel Phase 3
- Pembrolizumab Phase 2